PAYS · Paysign, Inc. · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-09-09 | Ngo Michael C |
Chief Innovation Officer |
Sell↓
Filing footnotes — Common Stock (Indirect)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.6400 to $12.8100, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person is the sole owner of Gamma Innovation LLC. |
Common Stock
(I)
|
79,925 |
| 2026-09-08 | Ngo Michael C |
Chief Innovation Officer |
Sell↓
Filing footnotes — Common Stock (Indirect)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.7125 to $13.1701, inclusive. The reporting person undertakes to provide Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person is the sole owner of Gamma Innovation LLC. |
Common Stock
(I)
|
70,075 |
| 2026-08-12 | Baker Jeffery Bradford |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.54 to $12.72, inclusive. The reporting person undertakes to provide Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
35,000 |
| 2026-08-06 | Newcomer Mark |
Director, CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.2444 to $12.4641, inclusive. The reporting person undertakes to provide Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
150,000 |
| 2026-08-04 | Triplett Dennis L |
Director |
Convert↓
Filing footnotes — Stock Grant (Direct)
On August 04, 2025, the reporting person received a grant of 20,000 shares of common stock vesting on August 04, 2026. As of the date of this filing, 20,000 shares of common stock have vested. |
Stock Grant
|
20,000 |
| 2026-08-04 | NEWMAN JEFFREY B |
Exec VP and General Counsel |
Convert↓
Filing footnotes — Stock Grant (Direct)
On August 04, 2025, the reporting person received a grant of 20,000 shares of common stock vesting on August 04, 2026. As of the date of this filing, 20,000 shares of common stock have vested. |
Stock Grant
|
20,000 |
| 2026-08-04 | HENRY DANIEL R |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
On August 4, 2025, the reporting person received a grant of 20,000 shares of common stock vesting on August 4, 2026. As of the date of this filing, 20,000 shares of common stock have vested. |
Common Stock
|
20,000 |
| 2026-08-04 | NEWMAN JEFFREY B |
Exec VP and General Counsel |
Convert↑
Filing footnotes — Common Stock (Direct)
On August 04, 2025, the reporting person received a grant of 20,000 shares of common stock vesting on August 04, 2026. As of the date of this filing, 20,000 shares of common stock have vested. |
Common Stock
|
20,000 |
| 2026-08-04 | Mina Bruce A |
Director |
Convert↓
Filing footnotes — Stock Grant (Direct)
On August 04, 2025, the reporting person received a grant of 20,000 shares of common stock vesting on August 04, 2026. As of the date of this filing, 20,000 shares of common stock have vested. |
Stock Grant
|
20,000 |
| 2026-08-04 | Triplett Dennis L |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
On August 04, 2025, the reporting person received a grant of 20,000 shares of common stock vesting on August 04, 2026. As of the date of this filing, 20,000 shares of common stock have vested. |
Common Stock
|
20,000 |
| 2026-08-04 | HENRY DANIEL R |
Director |
Convert↓
Filing footnotes — Stock Grant (Direct)
On August 4, 2025, the reporting person received a grant of 20,000 shares of common stock vesting on August 4, 2026. As of the date of this filing, 20,000 shares of common stock have vested. |
Stock Grant
|
20,000 |
| 2026-08-04 | Mina Bruce A |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
On August 04, 2025, the reporting person received a grant of 20,000 shares of common stock vesting on August 04, 2026. As of the date of this filing, 20,000 shares of common stock have vested. |
Common Stock
|
20,000 |
| 2026-07-31 | Cunningham Bradley Kramer |
CHIEF TECHNOLOGY OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |
Common Stock
|
22,430 |
| 2026-07-31 | Herman Joan M |
Director, EVP, Operations |
Convert↑
Filing footnotes — Common Stock (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Common Stock
|
36,000 |
| 2026-07-31 | Lanford Matthew Louis |
Director, Chief Payments Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Common Stock
|
64,000 |
| 2026-07-31 | Lanford Matthew Louis |
Director, Chief Payments Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |
Common Stock
|
25,185 |
| 2026-07-31 | Newcomer Mark |
Director, CEO, 10% Owner |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |
Common Stock
|
59,025 |
| 2026-07-31 | Strobo Robert |
Chief Legal Officer |
Convert↓
Filing footnotes — Stock Grant (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Stock Grant
|
64,000 |
| 2026-07-31 | Strobo Robert |
Chief Legal Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |
Common Stock
|
25,184 |
| 2026-07-31 | Lanford Matthew Louis |
Director, Chief Payments Officer |
Convert↓
Filing footnotes — Stock Grant (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Stock Grant
|
64,000 |
| 2026-07-31 | Strobo Robert |
Chief Legal Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Common Stock
|
64,000 |
| 2026-07-31 | Baker Jeffery Bradford |
Chief Financial Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Common Stock
|
64,000 |
| 2026-07-31 | Herman Joan M |
Director, EVP, Operations |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |
Common Stock
|
13,780 |
| 2026-07-31 | Baker Jeffery Bradford |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |
Common Stock
|
28,506 |
| 2026-07-31 | Herman Joan M |
Director, EVP, Operations |
Convert↓
Filing footnotes — Stock Grant (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Stock Grant
|
36,000 |
| 2026-07-31 | Newcomer Mark |
Director, CEO, 10% Owner |
Convert↓
Filing footnotes — Stock Grant (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Stock Grant
|
150,000 |
| 2026-07-31 | Newcomer Mark |
Director, CEO, 10% Owner |
Convert↑
Filing footnotes — Common Stock (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Common Stock
|
150,000 |
| 2026-07-31 | Baker Jeffery Bradford |
Chief Financial Officer |
Convert↓
Filing footnotes — Stock Grant (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Stock Grant
|
64,000 |
| 2026-07-29 | Newcomer Mark |
Director, CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.3720 to $9.39, inclusive. The reporting person undertakes to provide Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
50,000 |
| 2026-07-16 | Herman Joan M |
Director, EVP, Operations |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.58 to $8.87, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
28,000 |
| 2026-07-15 | Herman Joan M |
Director, EVP, Operations |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.48 to $8.71, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
31,904 |
| 2026-06-30 | Cunningham Bradley Kramer |
CHIEF TECHNOLOGY OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |
Common Stock
|
11,579 |
| 2026-06-26 | Herman Joan M |
Director, EVP, Operations |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.0071 to $8.0329, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
100,000 |
| 2026-06-11 | Mina Bruce A |
Director |
Sell↓
|
Common Stock
|
10,000 |
| 2026-06-01 | Cunningham Bradley Kramer |
CHIEF TECHNOLOGY OFFICER |
Sell↓
|
Common Stock
|
3,000 |
| 2026-06-01 | Herman Joan M |
Director, EVP, Operations |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.0001 to $8.0200, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
29,202 |
| 2026-06-01 | Mina Bruce A |
Director |
Sell↓
|
Common Stock
|
10,000 |
| 2026-05-29 | Cunningham Bradley Kramer |
CHIEF TECHNOLOGY OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.30 to $7.31, inclusive. The reporting person undertakes to provide Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
10,000 |
| 2026-05-29 | Baker Jeffery Bradford |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |
Common Stock
|
44,541 |
| 2026-05-27 | Strobo Robert |
Chief Legal Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |
Common Stock
|
39,235 |
| 2026-05-26 | Herman Joan M |
Director, EVP, Operations |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.0001 to $7.0249, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
22,534 |
| 2026-05-22 | Turner Matthew Baker |
PRES., PATIENT AFFORDABILITY |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock and performance-based restricted stock. |
Common Stock
|
50,681 |
| 2026-05-20 | Newcomer Mark |
Director, CEO, 10% Owner |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |
Common Stock
|
78,701 |
| 2026-05-18 | Cunningham Bradley Kramer |
CHIEF TECHNOLOGY OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock and performance-based restricted stock. |
Common Stock
|
12,369 |
| 2026-05-18 | Lanford Matthew Louis |
Director, Chief Payments Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |
Common Stock
|
12,755 |
| 2026-05-13 | Herman Joan M |
Director, EVP, Operations |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |
Common Stock
|
6,171 |
| 2026-05-08 | HENRY DANIEL R |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
On May 08, 2026, the reporting person received a grant of 20,000 shares of common stock vesting on May 08, 2027. |
Common Stock
|
20,000 |
| 2026-05-08 | NEWMAN JEFFREY B |
Exec VP and General Counsel |
Award↑
Filing footnotes — Common Stock (Direct)
On May 08, 2026, the reporting person received a grant of 20,000 shares of common stock vesting on May 08, 2027. |
Common Stock
|
20,000 |
| 2026-05-08 | Mina Bruce A |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
On May 08, 2026, the reporting person received a grant of 20,000 shares of common stock vesting on May 08, 2027. |
Common Stock
|
20,000 |
| 2026-05-08 | Triplett Dennis L |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
On May 08, 2026, the reporting person received a grant of 20,000 shares of common stock vesting on May 08, 2027. |
Common Stock
|
20,000 |